Respiratory Sciences News Today

The device attaches to an inhaler and monitors how often it is used, before feeding data to an app.

The death of 19-year-old Suhani Bhatnagar has brought the rare autoimmune disease under the spotlight. Experts give us the lowdown.

High levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including ‘brain fog’, giving a major clue as to one cause of their symptoms: blood clots.Dr Max Taquet and colleagues from the

MASKS and social distancing will not be brought back in to ease pressure on the NHS, the Government has insisted.Cases of both flu and Covid-19 have b

Synairgen PLC (AIM:SNG, OTC:SYGGF) will present findings next month that show that its SNG001 drug reduced the relative risk of recognised symptoms of long...

Analysis of 60 and 90-day data from Phase 3 SPRINTER trial in hospitalised COVID-19 patients showed that SNG001 reduced risk of recognised Long COVID symptoms Company to present full analysis

For fatigue, the relative risk reduction was 35.4%, for shortness of breath 28.3% and for loss of smell and/or taste 61.4%

Investegate announcements from 4d Pharma PLC, 4D pharma to host virtual KOL event

As the Government cuts the COVID isolation period to 5 days, researchers warn that 1 in 3 people may still be infectious after the 5-day quarantine period.

Experts are of the view that Omicron might accelerate the transition of coronavirus from pandemic to endemic, as per media report.